Literature DB >> 9460924

Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses.

J Zsíros1, M F Jebbink, V V Lukashov, P A Voûte, B Berkhout.   

Abstract

The prototype endogenous retrovirus HERV-K10 was identified in the human genome by its homology to the exogenous mouse mammary tumour virus. By analysis of a short 244 bp segment of the reverse transcriptase (RT) gene of other HERV-K10-like sequences, it has become clear that these elements represent an extended family consisting of multiple groups (the HML-1 to HML-6 subgroups). Some of these elements are transcriptionally active and contain an intact open reading frame for the RT protein, raising the possibility that this family is still expanding through retrotransposition. To better define the relationship of these endogenous retroviruses, we identified ten new members of the HML-2 subgroup. PCR was used to amplify reverse-transcribed RNA of a 595 bp region of the RT gene in a variety of human cell samples, including normal and leukaemic bone marrow and peripheral blood, placenta cells and a transformed T cell line. We provide an extensive phylogenetic analysis of the relationships for this cluster of HERV-K-related endogenous retroviral elements. Nucleotide diversity values for nonsynonymous versus synonymous codon positions indicate that moderately strong selection is or was operating on these retroviral RT gene segments. The evolution of this class of endogenous retroelements is discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9460924     DOI: 10.1099/0022-1317-79-1-61

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1.

Authors:  Marta J Gonzalez-Hernandez; Michael D Swanson; Rafael Contreras-Galindo; Sarah Cookinham; Steven R King; Richard J Noel; Mark H Kaplan; David M Markovitz
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

2.  Identification of an active reverse transcriptase enzyme encoded by a human endogenous HERV-K retrovirus.

Authors:  B Berkhout; M Jebbink; J Zsíros
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

3.  A revised nomenclature for transcribed human endogenous retroviral loci.

Authors:  Jens Mayer; Jonas Blomberg; Ruth L Seal
Journal:  Mob DNA       Date:  2011-05-04

4.  Papio cynocephalus endogenous retrovirus among old world monkeys: evidence for coevolution and ancient cross-species transmissions.

Authors:  R Mang; J Maas; A C van Der Kuyl; J Goudsmit
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Identification of novel porcine endogenous betaretrovirus sequences in miniature swine.

Authors:  T Ericsson; B Oldmixon; J Blomberg; M Rosa; C Patience; G Andersson
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

6.  The phylogeography of orangutan foamy viruses supports the theory of ancient repopulation of Sumatra.

Authors:  Ernst J Verschoor; Susan Langenhuijzen; Ilja Bontjer; Zahra Fagrouch; Henk Niphuis; Kristin S Warren; K Eulenberger; Jonathan L Heeney
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

7.  Allelic variation of HERV-K(HML-2) endogenous retroviral elements in human populations.

Authors:  Catriona Macfarlane; Peter Simmonds
Journal:  J Mol Evol       Date:  2004-11       Impact factor: 2.395

8.  Molecular characterization of a novel gammaretrovirus in killer whales (Orcinus orca).

Authors:  Sarah A Lamere; Judy A St Leger; Mark D Schrenzel; Simon J Anthony; Bruce A Rideout; Daniel R Salomon
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

9.  Human-specific integrations of the HERV-K endogenous retrovirus family.

Authors:  P Medstrand; D L Mager
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

10.  MHC Class I Regulation: The Origin Perspective.

Authors:  Alicja Sznarkowska; Sara Mikac; Magdalena Pilch
Journal:  Cancers (Basel)       Date:  2020-05-04       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.